Company Data

Genenta Science S.p.A.

Ticker
GNTA
Current Price
$3.94 3.68%
Market Cap
$71.8M
Price Target
Refer to Report
Volume
1.8K
52wk Range
$2.2 - $7.28
Advanced Market Data

Overview

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company’s product under development includes Temferon – a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy